Central line-related bacteraemia due to Roseomonas mucosa in a neutropenic patient with acute myeloid leukaemia in Piraeus, Greece

J Med Microbiol. 2006 Aug;55(Pt 8):1153-1156. doi: 10.1099/jmm.0.46634-0.

Abstract

A case of central venous catheter-related bacteraemia due to Roseomonas mucosa in a neutropenic patient with acute myelogenous leukaemia is reported. The patient was successfully treated with amikacin and piperacillin-tazobactam. The clinical isolate was identified as R. mucosa by 16S rRNA gene sequencing.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Adult
  • Amikacin / therapeutic use
  • Anti-Bacterial Agents / therapeutic use
  • Antimetabolites, Antineoplastic / administration & dosage
  • Antimetabolites, Antineoplastic / therapeutic use
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use
  • Bacteremia / drug therapy
  • Bacteremia / etiology*
  • Base Sequence
  • Catheterization, Central Venous / adverse effects*
  • Cytarabine / administration & dosage
  • Cytarabine / therapeutic use
  • Humans
  • Leukemia, Myeloid / complications*
  • Leukemia, Myeloid / drug therapy
  • Male
  • Methylobacteriaceae / classification
  • Methylobacteriaceae / genetics
  • Methylobacteriaceae / isolation & purification*
  • Molecular Sequence Data
  • Neutropenia / complications*
  • Penicillanic Acid / analogs & derivatives
  • Penicillanic Acid / therapeutic use
  • Phylogeny
  • Piperacillin / therapeutic use
  • Piperacillin, Tazobactam Drug Combination
  • RNA, Bacterial
  • RNA, Ribosomal, 16S / genetics
  • Vidarabine / analogs & derivatives
  • Vidarabine / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • RNA, Bacterial
  • RNA, Ribosomal, 16S
  • Cytarabine
  • Piperacillin, Tazobactam Drug Combination
  • Amikacin
  • Penicillanic Acid
  • Vidarabine
  • fludarabine
  • Piperacillin

Associated data

  • GENBANK/AM161051